The prevalence of diabetes mellitus worldwide is projected to rise from 2.8% in 2000 to 4.4% in 2030.1 Studies have […]Read More.
Researchers have revealed the important role of epigenetic regulation-mediated metabolic reprogramming in lung cancer’s capacity to resist molecular targeted therapy.Read More.
MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers.
While MYC programs breast cancer cells to build more macromolecules (anabolic metabolism), it also creates a metabolic vulnerability by making them more sensitive to a type of cell death known as apoptosis. Research Director Juha Klefstrom, PhD, University of Helsinki, Finland, has worked for a long time to exploit this apoptosis-sensitising effect of MYC in the battle against the cancer.
A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors.Read More.
Obesity is defined as an excessive accumulation of body fat that causes health problems. Current data indicate that the incidence of obesity has increased to epidemic proportions in the last 40 years.Read More.
Doha – October 14, 2018: Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have explored the links between type 2 diabetes and […]Read More.
Asthma is one of the commonest chronic diseases around the globe where it is reported that around 300 million people are suffering of this disease.Read More.